Company news

Skye Bioscience, Inc. news in 2022

Skye Bioscience, Inc.'s news releases, calls and decks from 2022, newest first.

View company

Skye Bioscience Receives FDA Authorization of Investigational New Drug Application for SBI-100 OE

December 19, 2022

Skye Bioscience Doses First Cohort of Participants in Phase 1 Clinical Trial of SBI-100 Ophthalmic Emulsion

December 15, 2022

Skye Bioscience Appoints Chris Twitty, PhD, as Chief Scientific Officer

December 12, 2022

Skye Bioscience Submits Investigational New Drug Application for SBI-100 Ophthalmic Emulsion to FDA

November 16, 2022

Skye Bioscience Initiates First-in-Human Phase 1 Clinical Trial for SBI-100

November 15, 2022

Skye Bioscience Closes Acquisition of Emerald Health Therapeutics

November 9, 2022

Skye Bioscience Stockholders Vote in Favor of Arrangement Agreement with Emerald Health Therapeutics, Inc.

September 29, 2022

Skye Bioscience Completes Drug Production for Phase 1 Clinical Study

September 19, 2022

Skye Bioscience Files Definitive Proxy Statement and Announces Stockholder Meeting Date

August 31, 2022

Skye Bioscience Selects NextPharma as Phase 2 Contract Drug Manufacturer

July 20, 2022

Skye Bioscience Updates Phase 1 Timeline

July 19, 2022

Skye Bioscience Receives Australian Ethics Committee Approval to Start First-in-Human Phase 1 Study of SBI-100 Ophthalmic Emulsion

June 29, 2022

Skye Bioscience Expands Cannabinoid Pharmaceutical Innovation Program with Leading Cannabinoid Medicinal Chemistry Groups

June 6, 2022

Skye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics

May 11, 2022

Skye Bioscience Engages Clinical Trial Site for Phase 1 Study in Agreement with CMAX Clinical Research

April 27, 2022

Skye Bioscience Retains Novotech as CRO for Phase 1 Trial of Glaucoma Drug Candidate

March 2, 2022

Skye Bioscience Reports Positive Results for SBI-100 in GLP Toxicology Study

February 15, 2022

Skye Bioscience Reports Potential Neuroprotective Benefit of SBI-100 In Preclinical Glaucoma Model

January 31, 2022

Decks in 2022